175 related articles for article (PubMed ID: 29901862)
21. Estimated cost efficacy of systemic treatments that are approved by the US Food and Drug Administration for the treatment of moderate to severe psoriasis.
D'Souza LS; Payette MJ
J Am Acad Dermatol; 2015 Apr; 72(4):589-98. PubMed ID: 25631851
[TBL] [Abstract][Full Text] [Related]
22. A randomized, 'head-to-head' pilot study comparing the effects of etanercept monotherapy vs. etanercept and narrowband ultraviolet B (NB-UVB) phototherapy in obese psoriasis patients.
Park KK; Wu JJ; Koo J
J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):899-906. PubMed ID: 22702846
[TBL] [Abstract][Full Text] [Related]
23. Non-invasive evaluation of tacalcitol plus puva versus tacalcitol plus UVB-NB in the treatment of psoriasis: "right-left intra-individual pre/post comparison design".
Brazzelli V; Barbagallo T; Prestinari F; Rona C; De Silvestri A; Trevisan V; Borroni G
Int J Immunopathol Pharmacol; 2005; 18(4):755-60. PubMed ID: 16388725
[TBL] [Abstract][Full Text] [Related]
24. A review of phototherapy protocols for psoriasis treatment.
Lapolla W; Yentzer BA; Bagel J; Halvorson CR; Feldman SR
J Am Acad Dermatol; 2011 May; 64(5):936-49. PubMed ID: 21429620
[TBL] [Abstract][Full Text] [Related]
25. [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].
Beani JC; Jeanmougin M
Ann Dermatol Venereol; 2010 Jan; 137(1):21-31. PubMed ID: 20110064
[TBL] [Abstract][Full Text] [Related]
26. Narrowband ultraviolet B inhibits innate cytosolic double-stranded RNA receptors in psoriatic skin and keratinocytes.
Rácz E; Prens EP; Kant M; Florencia E; Jaspers NG; Laman JD; de Ridder D; van der Fits L
Br J Dermatol; 2011 Apr; 164(4):838-47. PubMed ID: 21143460
[TBL] [Abstract][Full Text] [Related]
27. Digital ultraviolet therapy: a novel therapeutic approach for the targeted treatment of psoriasis vulgaris.
Werfel T; Holiangu F; Niemann KH; Schmerling O; Lüllau F; Zedler A; Sträter HD; Niebuhr M
Br J Dermatol; 2015 Mar; 172(3):746-53. PubMed ID: 25307476
[TBL] [Abstract][Full Text] [Related]
28. Review of an established UK home phototherapy service 1998-2011: improving access to a cost-effective treatment for chronic skin disease.
Cameron H; Yule S; Dawe RS; Ibbotson SH; Moseley H; Ferguson J
Public Health; 2014 Apr; 128(4):317-24. PubMed ID: 24726005
[TBL] [Abstract][Full Text] [Related]
29. TWEAK levels in psoriatic patients treated with narrowband ultraviolet B and methotrexate.
Hegazy EM; El Taieb MA; Ibrahim HM; Rageh EM; Ahmed NM; Ibrahim AK; Younis AM; Ali MA
J Cosmet Dermatol; 2024 May; 23(5):1905-1911. PubMed ID: 38299446
[TBL] [Abstract][Full Text] [Related]
30. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
[TBL] [Abstract][Full Text] [Related]
31. A randomized, observer-blinded trial of twice vs. three times weekly narrowband ultraviolet B phototherapy for chronic plaque psoriasis.
Cameron H; Dawe RS; Yule S; Murphy J; Ibbotson SH; Ferguson J
Br J Dermatol; 2002 Nov; 147(5):973-8. PubMed ID: 12410709
[TBL] [Abstract][Full Text] [Related]
32. Serum 5-S-cysteinyldopa levels in patients with psoriasis undergoing narrowband ultraviolet B phototherapy.
Kikuchi K; Wakamatsu K; Tada Y; Komine M; Ito S; Tamaki K
Clin Exp Dermatol; 2008 Nov; 33(6):750-3. PubMed ID: 18954414
[TBL] [Abstract][Full Text] [Related]
33. Efficacy assessment of UVA1 and narrowband UVB for treatment of scalp psoriasis.
Zhou J; Yi X; Li Y; Ding Y
Lasers Med Sci; 2018 Dec; 33(9):1979-1982. PubMed ID: 29915975
[TBL] [Abstract][Full Text] [Related]
34. Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque-type psoriasis: a randomized, placebo-controlled study.
Asawanonda P; Nateetongrungsak Y
J Am Acad Dermatol; 2006 Jun; 54(6):1013-8. PubMed ID: 16713455
[TBL] [Abstract][Full Text] [Related]
35. LCD plus NB-UVB reduces time to improvement of psoriasis vs. NB-UVB alone.
Bagel J
J Drugs Dermatol; 2009 Apr; 8(4):351-7. PubMed ID: 19363853
[TBL] [Abstract][Full Text] [Related]
36. Equating topical treatment of severe psoriasis to keeping money in a mattress.
Alikhan A; Sodhi N; Feldman SR
J Dermatolog Treat; 2009; 20(1):1-2. PubMed ID: 19127480
[No Abstract] [Full Text] [Related]
37. Comparison of the efficacy of local narrowband ultraviolet B (NB-UVB) phototherapy versus psoralen plus ultraviolet A (PUVA) paint for palmoplantar psoriasis.
Sezer E; Erbil AH; Kurumlu Z; Taştan HB; Etikan I
J Dermatol; 2007 Jul; 34(7):435-40. PubMed ID: 17584319
[TBL] [Abstract][Full Text] [Related]
38. Clinical evaluation of topical tacalcitol efficacy in extending the remission period between nb-UVB phototherapy cycles in psoriatic patients.
Prignano F; Buggiani G; Lotti T
Acta Biomed; 2009 Apr; 80(1):51-6. PubMed ID: 19705621
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of psoralen UV-A therapy vs. narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():11-21. PubMed ID: 22512676
[TBL] [Abstract][Full Text] [Related]
40. Broadband UVB revisited: is the narrowband UVB fad limiting our therapeutic options?
Pugashetti R; Lim HW; Koo J
J Dermatolog Treat; 2010 Nov; 21(6):326-30. PubMed ID: 19895327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
